<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180218038783N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-12-23</date_registration>
      <primary_sponsor>Babol University of Medical Sciences</primary_sponsor>
      <public_title>The effectiveness of olive and black seed oil combination in pain intensity and episiotomy wound healing</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of olive and black seed oil combination in pain intensity and episiotomy wound healing in prim parous women referred to hospitals under the auspices of Babol University of Medical Sciences</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-02-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>108</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/67451</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The researcher will select the samples according to the Inclusion criteria and assign them randomly (using the block randomized method) to two groups of intervention and routine care.
Eligible people are placed in one of three groups A: 36 people, B: 36 people, and C: 36 people, using permuted block randomization and open label. The size of the blocks is 6 and in each block each intervention group will be repeated twice. 18 blocks of 6 will be produced to create a sequence of size 108, Blinding description: In order to hide the list of random allocation, a special code will be assigned to each of the intervention groups, which only the main executor of the project (supervisor) will be aware of. Also, the second moderator, who is a student and evaluator of the study and the person who performs the statistical analysis, will not know about the codes assigned to the drugs.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Episiotomy pain intensity. Condition 2: Episiotomy wound repair.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: recipient of black seed oil and olive:All the subjects of the study will be taught how to follow the health tips after childbirth, and the samples of the intervention group will be taught how to use the container containing the oils. In such a way that they use the container containing black seed and olive oil with a dose of 10 drops locally and three times a day 24 hours after giving birth, for 10 days. The researcher also examines the severity of perineal pain and healing of episiotomy wound in the first 24 hours after delivery and ten days after that. Intervention 2: intervention group 2: Recipient of olive oil alone:All the subjects of the study will be taught how to follow the health tips after childbirth, and the samples of the intervention group will be taught how to use the container containing the oils. In such a way that they use a container containing olive oil with a dose of 10 drops locally and three times a day 24 hours after giving birth, for 10 days. The researcher also examines the severity of perineal pain and healing of episiotomy wound in the first 24 hours after delivery and ten days after that. Intervention 3: Control group:  They receive routine cares.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fereshteh Behmanesh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Babol University of Medical Sciences,  Keshavarz street, Kargar Ave</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4717647745</zip>
        <telephone>+98 11 3219 0504</telephone>
        <email>f.behmanesh2015@gmail.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fereshteh Behmanesh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Babol University of Medical Sciences,  Keshavarz street, Kargar Ave</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4717647745</zip>
        <telephone>+98 11 3219 0504</telephone>
        <email>f.behmanesh2015@gmail.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Primiparous women
Normal delivery with episiotomy
Having literacy
BMI &lt; 30</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>45 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>The personal unwillingness of the participants to continue the study,
Women who do not use oils regularly.
4th degree tear
History of diagnosed skin dermatitis
History of allergy and eczema diagnosed to plants
History of gestational diabetes and obvious</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G89</hc_code>
      <hc_code>O86.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Pain, not elsewhere classified</hc_keyword>
      <hc_keyword>Infection of obstetric surgical wound</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: recipient of black seed oil and olive:All the subjects of the study will be taught how to follow the health tips after childbirth, and the samples of the intervention group will be taught how to use the container containing the oils. In such a way that they use the container containing black seed and olive oil with a dose of 10 drops locally and three times a day 24 hours after giving birth, for 10 days. The researcher also examines the severity of perineal pain and healing of episiotomy wound in the first 24 hours after delivery and ten days after that.</i_keyword>
      <i_keyword>intervention group 2: Recipient of olive oil alone:All the subjects of the study will be taught how to follow the health tips after childbirth, and the samples of the intervention group will be taught how to use the container containing the oils. In such a way that they use a container containing olive oil with a dose of 10 drops locally and three times a day 24 hours after giving birth, for 10 days. The researcher also examines the severity of perineal pain and healing of episiotomy wound in the first 24 hours after delivery and ten days after that.</i_keyword>
      <i_keyword>Control group:  They receive routine cares.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The intensity of pain in the episiotomy area is based on the person's statements, where 0 means the least pain and 10 means the most possible pain. Timepoint: 24 hours after delivery (before the start of the intervention) and on the 10th day after starting the topical use of oils. Method of measurement: 10 cm pain ruler scale.</prim_outcome>
      <prim_outcome>Healing of episiotomy wound based on measuring the variables of swelling, bruising, redness and the distance between the two edges of episiotomy wound in lithotomy position. Timepoint: 24 hours after delivery (before the start of the intervention) and on the 10th day after starting the topical use of oils. Method of measurement: ٍEpisiotomy wound healing REEDA scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Burning and itching. Timepoint: The first ten days after delivery. Method of measurement: Examination.</sec_outcome>
      <sec_outcome>Episiotomy opening. Timepoint: The first ten days after delivery. Method of measurement: Examination.</sec_outcome>
      <sec_outcome>The need for painkillers. Timepoint: The first ten days after delivery. Method of measurement: Examination.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Babol University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-12-12</approval_date>
        <contact_name>Ethics Committee of Babol University of Medical Sciences</contact_name>
        <contact_address>Mazandaran, Babol, Ganj Afrooz Street, Babol University of Medical Sciences Babol Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
